Stockholders' Equity (Tables)

3 Months Ended

Mar. 31, 2026

Stockholders' Equity Note [Abstract]

Summary of Stock Option Activity

The following table summarizes the option activity under the 2020 Plan and 2015 Plan during the three months ended March 31, 2026:

	Number of shares			Weighted average exercise price		Weighted average remaining contractual term (in years)		Aggregate Intrinsic Value (in thousands)
Outstanding at December 31, 2025		10,737,203		$	8.22		6.6	$	134
Granted		2,039,892			1.95
Exercised		(3,719	)		1.74
Forfeited		(1,297,700	)		14.02
Outstanding at March 31, 2026		11,475,676			6.45		7.2		1,072
Exercisable at March 31, 2026		5,217,009			10.99		5.1		29
Vested and expected to vest at March 31, 2026		11,475,676		$	6.45		7.2	$	1,072

Summary of Restricted Stock Unit Activity

The following table summarizes the restricted stock unit activity under the 2020 Plan during the three months ended March 31, 2026:

	Number of shares			Weighted average grant date fair value per share		Weighted average remaining contractual term (in years)
Outstanding at December 31, 2025		648,959		$	4.34		1.2
Granted		585,547			1.93
Vested		(208,240	)		5.03
Forfeited		(20,015	)		3.00
Outstanding at March 31, 2026		1,006,251		$	2.82		2.0

Summary of Share-based Compensation Expense

Share-based compensation expense for the three months ended March 31, 2026 and 2025 was as follows (in thousands):

	Three Months Ended March 31,
	2026		2025
Research and development	$	732	$	1,113
General and administrative		1,166		1,721
Total share-based compensation	$	1,898	$	2,834